-
Gland Pharma
2,969.85 3,039.00(%) -
Power Fin.Corpn.
357.70 486.45(%) -
IFCI
107.45 107.45(%) -
Shriram Finance
1,036.40 584.25(%) -
Tata Technolog.
796.45 507.50(%) -
ESDS Software
895.55 895.55(%) -
Lenskart Solut.
694.75 694.75(%) -
Netweb Technol.
5,170.00 2,514.75(%) -
Lumino Inds
122.00 122.00(%) -
Kesar India
1,180.00 1,341.00(%) -
Multi Comm. Exc.
3,287.00 3,479.80(%) -
Tejas Networks
623.90 644.75(%) -
RBL Bank
417.00 417.00(%) -
ICICI AMC
2,960.00 2,528.90(%) -
Polycab India
8,254.00 6,660.50(%) -
New India Assura
234.60 234.60(%) -
Wockhardt
2,107.95 2,420.00(%) -
Angel One
308.20 360.20(%) -
Jindal Worldwide
57.06 57.06(%) -
Lalithaa Jewel
308.55 308.55(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Vanta Bioscience Ltd Miscellaneous
- Indian Private
- BSE Code : 71082.0
- ISIN : INE695X01011
-
Today’s Low
19.64 -
Today’s High
19.64
-
Open
19.64 -
Perv Close
20.67 -
52W Low
14.71 -
52W High
29.00
Key Indicators
-
P/E(TTM)
115.53
-
Mar.Cap (₹Cr.)
13.97
-
Div & Yield %
0.00
-
Book Value(₹)
29.88
-
Debt-Equity Ratio
-4.98
-
AGM Date
13-Aug-2026
-
EPS
0.17
-
P/E Ratio
115.53
Financials Ratios
-
Debt-Equity Ratio
3.61
-
Mar.Cap (₹Cr.)
13.97
-
RONW (%)
0.00
-
ROCE (%)
0.00
Score Board
-
Equity (₹ in Cr.)
7.11
-
BV (₹)
29.90
-
Sales( ₹ in Cr.)
1.82
-
NP (in Cr.)
0.12
-
NP Var(%)
105.0
-
Div%
0.0
-
CPS (₹)
0.70
-
EPS (₹)
0.20
-
Traded Value (₹ in Lakhs)
13.97
-
52 Week High
29.00
-
52 Week Low
14.71
-
Price BSE
20.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
13.97
-
P/C Ratio
28.00
-
P/E Ratio
118.70
-
Price Vs.BV
0.20
-
05-Sep-2026( 05:48)
Corporate News - Vanta... - <p>Vanta Bioscience Limited in...
-
28-May-2026( 12:47)
Corporate News - Vanta... - Vanta Bioscience will hold a...
-
11-Nov-2025( 02:10)
Corporate News - Vanta... - Vanta Bioscience will hold a...
-
20-Sep-2025( 01:56)
Corporate News - Vanta... - Vanta Bioscience announced th...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 1.13 | 8.56 | 5.17 | 9.35 | 10.04 | 14.11 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1.13 | 8.56 | 5.17 | 9.35 | 10.04 | 14.11 |
| Other Income | 0.04 | 0.05 | 0.63 | 0.17 | 0.02 | 0.11 |
| Stock Adjustments | -0.99 | 0.38 | -0.11 | 0.00 | 0.00 | 0.00 |
| Total Income | 0.18 | 8.99 | 5.69 | 9.52 | 10.06 | 14.22 |
| EXPENDITURE : | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Power and Fuel Cost | 0.25 | 0.82 | 0.62 | 0.55 | 0.54 | 0.99 |
| Employee Cost | 0.58 | 2.68 | 2.75 | 2.57 | 2.51 | 3.79 |
| Other Manufacturing Expenses | 0.18 | 0.77 | 0.67 | 0.86 | 0.99 | 1.46 |
| Selling and Administration Expenses | 0.78 | 1.01 | 1.48 | 1.97 | 1.95 | 3.55 |
| Miscellaneous Expenses | 0.00 | 0.01 | 0.00 | 0.00 | 0.16 | 0.00 |
| Employee Benefit Expenses | 0.58 | 2.68 | 2.75 | 2.57 | 2.51 | 3.79 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1.79 | 5.29 | 5.53 | 5.95 | 6.14 | 9.80 |
| Operating Profit | -1.62 | 3.70 | 0.15 | 3.57 | 3.92 | 4.43 |
| Interest | 0.66 | 2.42 | 3.11 | 2.11 | 2.06 | 1.95 |
| Gross Profit | -2.28 | 1.28 | -2.96 | 1.46 | 1.86 | 2.48 |
| Depreciation | 0.44 | 1.24 | 1.25 | 1.32 | 1.25 | 1.19 |
| Profit Before Tax | -2.72 | 0.04 | -4.21 | 0.14 | 0.61 | 1.29 |
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.06 | -0.01 | 0.03 | 0.06 | 0.13 | 0.19 |
| Reported Net Profit | -2.66 | 0.05 | -4.24 | 0.08 | 0.47 | 0.98 |
| Extraordinary Items | 0.00 | 0.04 | 0.00 | 0.00 | 0.01 | 0.02 |
| Adjusted Net Profit | -2.66 | 0.01 | -4.24 | 0.08 | 0.46 | 0.96 |
| Adjustment below Net Profit | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.22 |
| P & L Balance brought forward | -1.73 | -1.78 | 2.46 | 2.39 | 1.92 | 0.72 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -4.39 | -1.73 | -1.78 | 2.46 | 2.39 | 1.92 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -4.21 | 0.08 | -6.71 | 0.12 | 0.75 | 1.55 |
| Earnings Per Share(Adj)-Unit Curr | -4.21 | 0.08 | -6.71 | 0.12 | 0.75 | 1.55 |
| Book Value | 27.14 | 31.36 | 31.28 | 38.01 | 37.88 | 37.14 |
| Book Value(Adj)-Unit Curr | 27.14 | 31.36 | 31.28 | 38.01 | 37.88 | 37.14 |
